IL2 and neoplasm: Therefore, we created another mouse model with host NK cells present but inhibited in their effector function by HLA-Cw3 ligand present on tumor cells (Figure 3C) and then injected IL-2 NK cells lacking inhibitory receptors for HLA-Cw3.